Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Auswirkungen Eines Probiotischen Nahrungsergänzungsmittels Auf Das Darmmikrobiom Von Schlaganfallpatienten (PRISE)

NCT04954846 is registered in ClinicalTrials.gov with Ludwig-Maximilians - University of Munich as lead sponsor.

NCT NCT04954846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04954846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Auswirkungen Eines Probiotischen Nahrungsergänzungsmittels Auf Das Darmmikrobiom Von Schlaganfallpatienten (PRISE)
Lead sponsor
Ludwig-Maximilians - University of Munich
Phase
Not applicable
Overall status
Unknown status
Start date
January 18, 2021
Completion date
December 30, 2023
Enrollment
157 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dysbiosis, stroke, ischemic